Showing 8,581 - 8,600 results of 18,490 for search 'significant ((((((step decrease) OR (greater decrease))) OR (a decrease))) OR (mean decrease))', query time: 0.67s Refine Results
  1. 8581

    Supplementary file 1_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

    Published 2025
    “…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …”
  2. 8582

    Supplementary file 4_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

    Published 2025
    “…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …”
  3. 8583

    Supplementary file 6_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

    Published 2025
    “…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …”
  4. 8584

    Supplementary Material for: Adverse Prognosis in Membranous Nephropathy with PLA2R1 Epitope Spreading: A Prospective Study by figshare admin karger (2628495)

    Published 2025
    “…In a univariate analysis, multi-domain recognition decreases the probability of remission[HR, 0.38 (95% CI, 0.16-0.87), P = 0.022]. …”
  5. 8585
  6. 8586

    Polygenic adaptation analysis results for the pairwise and multi-population tests for polygenic adaptation (see Methods). by Olivia A. Gray (20700832)

    Published 2025
    “…The SNP no. column shows how many SNPS are included in the test at this significance threshold. Significant <i>p</i>-values are highlighted in green (figures for all significant Multi-population tests in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1011570#pgen.1011570.s006" target="_blank">S6 Fig</a>). …”
  7. 8587

    Data Sheet 1_Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis.pdf by Tianmin Huang (20561477)

    Published 2025
    “…HU, in transfusion-dependent β-thalassemia patients, was related to a significant decrease in transfusion requirements [a pooled RR of 0.37 and a pooled good RR of 0.65 (95% CI, 0.53–0.76)]; in transfusion-independent β-thalassemia patients, it was correlated to an excellent raise in Hb levels [a pooled RR of 0.20 (95% CI, 0.08–0.35) and a pooled good RR of 0.53 (95% CI, 0.41–0.65)]. …”
  8. 8588
  9. 8589

    Table2_Causal relationship between antihypertensive drugs and Hashimoto’s thyroiditis: a drug-target Mendelian randomization study.xlsx by Bing Cui (179696)

    Published 2024
    “…Moreover, genetically mimicking the use of loop diuretics (OR [95% CI]: 0.94 [0.91, 0.97]; p = 3.57×10<sup>-5</sup>) and thiazide diuretics (0.98 [0.96, 0.99]; p = 3.83×10<sup>-3</sup>) showed a significant association with a decreased risk of HT only in European population. …”
  10. 8590
  11. 8591

    Image1_Causal relationship between antihypertensive drugs and Hashimoto’s thyroiditis: a drug-target Mendelian randomization study.tif by Bing Cui (179696)

    Published 2024
    “…Moreover, genetically mimicking the use of loop diuretics (OR [95% CI]: 0.94 [0.91, 0.97]; p = 3.57×10<sup>-5</sup>) and thiazide diuretics (0.98 [0.96, 0.99]; p = 3.83×10<sup>-3</sup>) showed a significant association with a decreased risk of HT only in European population. …”
  12. 8592

    Table4_Causal relationship between antihypertensive drugs and Hashimoto’s thyroiditis: a drug-target Mendelian randomization study.xlsx by Bing Cui (179696)

    Published 2024
    “…Moreover, genetically mimicking the use of loop diuretics (OR [95% CI]: 0.94 [0.91, 0.97]; p = 3.57×10<sup>-5</sup>) and thiazide diuretics (0.98 [0.96, 0.99]; p = 3.83×10<sup>-3</sup>) showed a significant association with a decreased risk of HT only in European population. …”
  13. 8593

    Data from: '<b>From climate warming to accelerated cellular ageing: an experimental study in a wild passerine bird'</b> by Antoine Stier (3596369)

    Published 2025
    “…</i> non-significant decrease in the gene expression of telomerase and protective shelterin). …”
  14. 8594
  15. 8595
  16. 8596
  17. 8597

    Table5_Causal relationship between antihypertensive drugs and Hashimoto’s thyroiditis: a drug-target Mendelian randomization study.xlsx by Bing Cui (179696)

    Published 2024
    “…Moreover, genetically mimicking the use of loop diuretics (OR [95% CI]: 0.94 [0.91, 0.97]; p = 3.57×10<sup>-5</sup>) and thiazide diuretics (0.98 [0.96, 0.99]; p = 3.83×10<sup>-3</sup>) showed a significant association with a decreased risk of HT only in European population. …”
  18. 8598

    Data Sheet 3_Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis.pdf by Tianmin Huang (20561477)

    Published 2025
    “…HU, in transfusion-dependent β-thalassemia patients, was related to a significant decrease in transfusion requirements [a pooled RR of 0.37 and a pooled good RR of 0.65 (95% CI, 0.53–0.76)]; in transfusion-independent β-thalassemia patients, it was correlated to an excellent raise in Hb levels [a pooled RR of 0.20 (95% CI, 0.08–0.35) and a pooled good RR of 0.53 (95% CI, 0.41–0.65)]. …”
  19. 8599

    Image2_Causal relationship between antihypertensive drugs and Hashimoto’s thyroiditis: a drug-target Mendelian randomization study.tif by Bing Cui (179696)

    Published 2024
    “…Moreover, genetically mimicking the use of loop diuretics (OR [95% CI]: 0.94 [0.91, 0.97]; p = 3.57×10<sup>-5</sup>) and thiazide diuretics (0.98 [0.96, 0.99]; p = 3.83×10<sup>-3</sup>) showed a significant association with a decreased risk of HT only in European population. …”
  20. 8600

    Data Sheet 2_Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis.pdf by Tianmin Huang (20561477)

    Published 2025
    “…HU, in transfusion-dependent β-thalassemia patients, was related to a significant decrease in transfusion requirements [a pooled RR of 0.37 and a pooled good RR of 0.65 (95% CI, 0.53–0.76)]; in transfusion-independent β-thalassemia patients, it was correlated to an excellent raise in Hb levels [a pooled RR of 0.20 (95% CI, 0.08–0.35) and a pooled good RR of 0.53 (95% CI, 0.41–0.65)]. …”